NEURODEGENERATIVE DISEASES:
BIOLOGY & THERAPEUTICS
December 4 - 7, 2008
Abstract Deadline: September 17, 2008

Organizers:
Samuel Gandy, Mount Sinai School of Medicine
Virginia Man-Yee Lee, University of Pennsylvania
Marcy MacDonald, Massachusetts General Hospital

past program

You are cordially invited to participate in the fifth meeting on Neurodegenerative Diseases: Biology & Therapeutics, which will be held at Cold Spring Harbor Laboratory. The meeting will begin with dinner and the first session on the evening of Thursday, December 4, and will conclude with an evening banquet on, Saturday December 6, with normal departure on the morning of Sunday December 7.

Rational drug discovery for neurodegenerative diseases has begun to yield compounds and approaches which are entering the clinic. In order for these human studies to yield a maximum of information and success, it is now more crucial than ever for scientists from academia and industry to have forums for the exchange of data and ideas.

This meeting will consist of six to seven sessions, each of which will be composed of one talk by the session chair, one talk by an invited speaker, and several additional talks selected from the submitted abstracts. It is expected that half of the session chairs and speakers (invited and from submitted abstracts) will be from each "sector": i.e., half from academia and half from industry.

Topics:
Triplet Repeat Diseases
Tauopathies
Synucleinopathies
Cerebral Amyloidoses
Amyotrophic Lateral Sclerosis
Mechanisms of Neurodegeneration
Current Therapies and Prevention
Cell and Gene Transfer
Genetics, Genomics & Patient Selection
Innovative Clinical Study Design

Confirmed Speakers:
Laurel Beckett, University of California, Davis
Kurt Brunden, University of Pennsylvania
Neil Buckholtz, National Institutes of Health
Steven DeKosky, University of Pittsburgh
Karen Duff, Columbia University
Michelle Ehrlich, Mount Sinai School of Medicine
James Gusella, Massachusetts General Hospital
Todd Golde, Mayo Clinic College of Medicine
Michael Grundman, Elan Pharmaceuticals
Steven Hersch, Harvard University
David Hung, Medivation
Adrian Ivinson, Harvard Medical School
William Jagust, University of California, Berkeley
Michael Kauffman, Epix Pharmaceuticals, Inc
Philippe Marambaud, North Shore LIJ
Colin Masters, University of Melbourne, Australia
Richard Myers, Boston University
Ronald Petersen, Mayo Clinic
Jeffrey Rothstein, Johns Hopkins University School of Medicine
Leslie Shaw, University of Pennsylvania
Daniel Skovronsky, University of Pennsylvania
Holly Soares, Pfizer
Toshiharu Suzuki, Hokkaido University, Japan
Rudolph Tanzi, Massachusetts General Hospital
Bryan Traynor, National Institutes of Health
John Trojanowski, Univ.of Pennsylvania School of Medicine
Erich Wanker, Max-Delbruck, Germany
Michael Weiner, Universtiy of California, San Francisco
Kenton Zavitz, Myriad Pharmaceuticals

Abstracts should contain new and unpublished material. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. Status (talk/poster) of abstracts will be posted on our website as soon as decisions have been made by the organizers. Please bring this notice to the attention of any of your colleagues who may be interested.

We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. We have applied for funds from government and industry to partially support graduate students and postdocs. Please register and apply in writing to meetings@cshl.edu stating eligibility and need.

We look forward to seeing you at Cold Spring Harbor in November/December.

---

Regular packages are all inclusive and cover registration, food, housing, parking, wine-and-cheese party, lobster banquet, etc. No Housing packages include all costs except housing. Full payment is due 4 weeks prior to the meeting.